Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Vomiting × netupitant, palosentron drug combination × Clear all

Status

Sponsor Class

Study Type

Interventional 5 Observational 1

Sponsor

Conditions

Interventions

netupitant, palosentron drug combination 1 Olanzapine 1 NDC80 protein, human 1 Immunoenzyme Techniques 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03649230 2023-08-18

EVOLVE_CINV

Purdue Pharma, Canada

207 enrolled 10 charts

Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡